Cancer Stem Cells Market - (By Type - Blood Cancer, Breast Cancer, Brain Cancer, Skin Cancer, Colorectal Cancer; Market By End User - Oncology Center, Diagnostic & Research Laboratories) - Global Industry Size, Share, Trends, and Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 0

Introduction

Cancer is a condition associated with the uncontrollable growth of the cell in the body. Over 100 types of cancer are observed in the human body. Stem cells are cells which are required for the maintenance of healthy tissue, where cells continually been replaced. They are undifferentiated cells and thus has got a huge application in the treatment of the various diseases. A number of different types treatment are used in the cure of cancer however, stem cell is expected to be one of the most prominent therapy for the treatment with minimal side effects. Many major pharmaceutical and research organization are trying to introduce new and advanced treatment options.

Market Dynamics

The major driving factors for the market are increasing prevalence of cancer, increasing need for the better treatment and increasing government support. According to American Cancer Society, about 1.7 million new cancer cases are expected to be diagnosed by the end of 2018 and approximately 609,640 Americans are expected to die of cancer in 2018 i.e. 1,670 deaths per day. Increasing spending on research and development has boosted the growth of the market. Cancer Research UK have spent USD 518 million on cancer research across the U.K to accelerate progress and increase cancer surviving rate by 75% by 2034. The organization is also aiming to increase the proportion of GDP spend on R&D to 2.6% by 2023. Additionally, increasing per capita income of the people, favorable reimbursement policies, and increasing awareness about availability of treatment have supported the growth of market.

However, availability of the alternative treatment may slow the growth of the market.

Market Classification and Overview

The global cancer stem cells market is segmented into types, end users, and region.

On the basis of types, the market is segmented into breast cancer, blood cancer, brain cancer, colorectal cancer, skin cancer, and others.

Based on the end users, the market is segmented into oncology center, diagnostic & research laboratories, and others.

Regional Overview

Geographically, the global cancer stem cells market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is one of the leading markets across the globe owing to high prevalence of various cancers in region including lung cancer and breast cancer, and ovarian cancer, among others. According to the American Cancer Society, in 2016, over 15.5 million people survived of cancer and the number is expected to reach 20.3 million by 2026 in the U.S.  Additionally, to meet the upcoming demand and grab the major share of the market, most of the key players are heavily investing in research and development activities and using modern technologies in R&D in this region which has supported the growth of the market.

Increasing government support and growing expenditure on R&D are projected to drive the Europe cancer stem cell market. France and Germany are the largest contributors to Europe market growth owing to increasing investments in health care and cancer research. Asia Pacific is the fastest growing region. However, Latin American and the Middle Eastern countries including Saudi Arabia, United Arab Emirates (UAE), and Kuwait are projected to drive the LAMEA market as result of increasing demand for specialty care services and growing healthcare sector.  On the other hand, Africa is estimated to witness moderate growth.

Report Coverage

Market

Cancer Stem Cells Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Type, End-Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

The cancer stem cells market comprises of some of the major players such as

  • Celula, Inc.
  • AdnaGen GmbH
  • Epic Sciences, Inc.
  • AVIVA Biosciences Corporation
  • Fluxion Biosciences, Inc.
  • Rarecells USA, Inc.
  • Advanced Cell Diagnostics, Inc.
  • Silicon Biosystems, S.p.A.
  • Others

Market Segmentation

Market By Type

  • Blood Cancer
  • Breast Cancer
  • Brain Cancer
  • Skin Cancer
  • Colorectal Cancer
  • Others

Market By End-User

  • Oncology Center
  • Diagnostic & Research Laboratories
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Biomedical Refrigerators and Freezers Market (By Product: Plasma Freezers, Blood Bank Refrigerators, Lab Refrigerators, Lab Freezers, Ultra-low Temperature Freezers, Shock Freezers; By End-use: Blood Banks, Pharmacies, Hospitals, Research Labs, Diagnostic Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Biomedical freezers and refrigerators are medicinal devices that are specially used to store up various medical samples such as vaccines, blood products, medicines, flammable chemicals and enzymes. Biomedical freezers and refrigerators are used in research laboratories, hospitals, pharmacies, diagnostic centers, and blood banks. Biomedical freezers and refrigerators offer optimal storage of me

Point of Care Testing Market (By Product: Glucose monitoring [Strips, Meters, Lancets], Cardiometabolic testing products [Cardiac marker testing products, Blood Gas/Electrolytes testing products, HBA1C testing products], Infectious disease testing products [Influenza testing products, HIV testing products, Hepatitis C testing products, Sexually Transmitted Disease (STD) testing products, Healthcare-Associated Infection (HAI) testing products, Respiratory infection testing products, Tropical disease testing products, Other infectious diseases testing products], Coagulation testing products [PT/INR testing products, Activated Clotting Time (ACT/APTT) testing products], Pregnancy and fertility testing products [Pregnancy testing products, Fertility testing products], Tumor/Cancer marker testing products, Urinalysis testing products, Cholesterol testing products, Hematology testing products, Drug-of-Abuse (DoA) testing products, Fecal occult testing products, Other products; By Technology: Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, Agglutination assays, Flow-Through, Solid phase, Biosensors; By Prescription: OTC testing, Prescription-based testing; By Application: Cardio metabolic testing, Infectious disease testing, Nephrology testing, Drug-of-Abuse (DoA) testing, Blood glucose testing, Pregnancy testing, Cancer biomarker testing, Other applications; By End-user: Hospitals, Diagnostic centers, Research laboratories, Home-care settings, Other end-uses) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global point of care testing market is expected develop at a CAGR of over 7.4% throughout the forthcoming years and industry is worth at over USD 21.7 billion in 2018 and is likely to rise up to USD 38.40 billion by 2026. Market Dynamics Increment in number of in

Oncology Information Systems Market (By Products & Services: Software [Patient Information Systems, Treatment Planning Systems], Professional Services; By Application: Medical Oncology, Surgical Oncology, Radiation Oncology) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Oncology Information Systems is well known for managing portfolios by software across healthcare settings, such as hospitals, research laboratories, and clinics. In addition, this software is useful to envisage treatment outcomes; accordingly, this software helps to plan the patient’s treatment, and also provide information about cancer patient among overall heal

Image-Guided & Robot-Assisted Surgical Procedures Market (By Specialty Type: Gynecologic Surgery, Urologic Surgery, General Surgery, Cardiothoracic Surgery, Head & Neck Specialties) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Image-guided & robot-assisted surgical procedures market size is anticipated to around USD 6.0 billion by 2026, this market is anticipated to grow with 14.9% CAGR during the forecast time period. Market Dynamics Speedy technological progressions in

Home Healthcare Market (By Component: Equipment [Therapeutic, Diagnostic, Mobility assist], Services [Rehabilitation, Unskilled home care, Respiratory therapy services, Infusion therapy services, Telemetry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global home healthcare market size is anticipated to around USD 528.2 billion by 2026, this market is anticipated to grow with 7.9% CAGR during the forecast time period. Need for home healthcare services is increasing inferable from advantages, for example, enhanced patient result, long term care, cost proficiency, end of superfluous hospitalizatio

Cart Summary